BioTelemetry Inc

Find Ratings Reports
BEAT : NASDAQ : Health Care
$29.1 up 0.5 | 1.75%
Today's Range: 28.7 - 29.5
Avg. Daily Volume: 327400.0
03/29/17 - 4:00 PM ET

Financial Analysis


BIOTELEMETRY INC's gross profit margin for the fourth quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. BIOTELEMETRY INC has strong liquidity. Currently, the Quick Ratio is 1.58 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

At the same time, stockholders' equity ("net worth") has greatly increased by 82.95% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY16 Q4 FY15
Net Sales ($mil)53.9646.77
EBITDA ($mil)8.536.84
EBIT ($mil)4.883.47
Net Income ($mil)40.452.85


Balance Sheet Q4 FY16 Q4 FY15
Cash & Equiv. ($mil)23.0518.99
Total Assets ($mil)198.98124.14
Total Debt ($mil)25.4523.58
Equity ($mil)138.9175.93


Profitability Q4 FY16 Q4 FY15
Gross Profit Margin66.1666.08
EBITDA Margin15.8114.61
Operating Margin9.057.42
Sales Turnover1.051.44
Return on Assets26.855.98
Return on Equity38.469.78
Debt Q4 FY16 Q4 FY15
Current Ratio1.891.97
Debt/Capital0.150.24
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q4 FY16 Q4 FY15
Shares outstanding (mil)28.2627.28
Div / share0.00.0
EPS1.30.1
Book value / share4.922.78
Institutional Own % n/a n/a
Avg Daily Volume313313.0321740.0

Valuation


BUY. BIOTELEMETRY INC's P/E ratio indicates a significant discount compared to an average of 26.92 for the Health Care Providers & Services industry and a significant discount compared to the S&P 500 average of 26.33. For additional comparison, its price-to-book ratio of 5.30 indicates a significant premium versus the S&P 500 average of 2.93 and a significant premium versus the industry average of 3.32. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
BEAT 15.06 Peers 26.92   BEAT 18.95 Peers 12.27

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

BEAT is trading at a significant discount to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

BEAT is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
BEAT 24.23 Peers 15.47   BEAT NM Peers 1.24

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

BEAT is trading at a significant premium to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

BEAT's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
BEAT 5.30 Peers 3.32   BEAT 565.38 Peers 20.20

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

BEAT is trading at a significant premium to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

BEAT is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
BEAT 3.53 Peers 0.85   BEAT 16.70 Peers 11.72

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

BEAT is trading at a significant premium to its industry.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

BEAT has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades